HCW Biologics (HCWB) Competitors $0.75 -0.20 (-20.76%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends HCWB vs. LMNL, ENLV, CYAD, SGTX, ANRO, RANI, SCLX, INMB, VXRT, and DERMShould you be buying HCW Biologics stock or one of its competitors? The main competitors of HCW Biologics include Liminal BioSciences (LMNL), Enlivex Therapeutics (ENLV), Celyad Oncology (CYAD), Sigilon Therapeutics (SGTX), Alto Neuroscience (ANRO), Rani Therapeutics (RANI), Scilex (SCLX), INmune Bio (INMB), Vaxart (VXRT), and Journey Medical (DERM). These companies are all part of the "medical" sector. HCW Biologics vs. Liminal BioSciences Enlivex Therapeutics Celyad Oncology Sigilon Therapeutics Alto Neuroscience Rani Therapeutics Scilex INmune Bio Vaxart Journey Medical HCW Biologics (NASDAQ:HCWB) and Liminal BioSciences (NASDAQ:LMNL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability. Does the media prefer HCWB or LMNL? In the previous week, HCW Biologics had 9 more articles in the media than Liminal BioSciences. MarketBeat recorded 9 mentions for HCW Biologics and 0 mentions for Liminal BioSciences. HCW Biologics' average media sentiment score of 0.34 beat Liminal BioSciences' score of 0.00 indicating that HCW Biologics is being referred to more favorably in the media. Company Overall Sentiment HCW Biologics Neutral Liminal BioSciences Neutral Is HCWB or LMNL more profitable? Liminal BioSciences has a net margin of 248.35% compared to HCW Biologics' net margin of -1,067.82%. Liminal BioSciences' return on equity of -88.44% beat HCW Biologics' return on equity.Company Net Margins Return on Equity Return on Assets HCW Biologics-1,067.82% -2,516.84% -132.95% Liminal BioSciences 248.35%-88.44%-64.15% Do institutionals and insiders believe in HCWB or LMNL? 3.0% of HCW Biologics shares are owned by institutional investors. Comparatively, 0.7% of Liminal BioSciences shares are owned by institutional investors. 49.9% of HCW Biologics shares are owned by insiders. Comparatively, 2.2% of Liminal BioSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, HCWB or LMNL? HCW Biologics has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Liminal BioSciences has a beta of 1.03, meaning that its stock price is 3% more volatile than the S&P 500. Which has better earnings & valuation, HCWB or LMNL? Liminal BioSciences has lower revenue, but higher earnings than HCW Biologics. HCW Biologics is trading at a lower price-to-earnings ratio than Liminal BioSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHCW Biologics$2.84M10.00-$24.99M-$1.00-0.75Liminal BioSciences$310K85.00$380K$0.2929.31 Does the MarketBeat Community favor HCWB or LMNL? Liminal BioSciences received 8 more outperform votes than HCW Biologics when rated by MarketBeat users. However, 100.00% of users gave HCW Biologics an outperform vote while only 48.28% of users gave Liminal BioSciences an outperform vote. CompanyUnderperformOutperformHCW BiologicsOutperform Votes6100.00% Underperform VotesNo VotesLiminal BioSciencesOutperform Votes1448.28% Underperform Votes1551.72% SummaryLiminal BioSciences beats HCW Biologics on 9 of the 15 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get HCW Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for HCWB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCWB vs. The Competition Export to ExcelMetricHCW BiologicsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.39M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-0.755.5095.1214.22Price / Sales10.00375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book-2.8910.276.976.37Net Income-$24.99M$153.22M$118.73M$225.56M7 Day Performance142.91%-1.19%-1.22%-0.02%1 Month Performance40.01%-6.71%-3.07%2.04%1 Year Performance-31.14%32.39%32.52%28.00% HCW Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCWBHCW Biologics1.1175 of 5 stars$0.75-20.8%N/A-12.3%$28.39M$2.84M-0.7540Gap DownLMNLLiminal BioSciencesN/A$8.50+0.1%N/A+0.0%$26.35M$310,000.0029.31251ENLVEnlivex Therapeutics3.075 of 5 stars$0.83-14.9%$6.00+622.8%-42.9%$17.77MN/A-0.7170News CoverageGap UpHigh Trading VolumeCYADCelyad OncologyN/A$0.60flatN/A+0.0%$15.91M$110,000.000.0095High Trading VolumeSGTXSigilon TherapeuticsN/A$22.47-2.6%N/A+0.0%$56.40M$12.94M-1.8462ANROAlto Neuroscience3.8056 of 5 stars$4.11-3.7%$20.00+386.6%N/A$110.85M$210,000.000.00N/AAnalyst RevisionRANIRani Therapeutics3.1632 of 5 stars$2.02-1.5%$11.71+479.9%+2.5%$107.89M$2.72M0.00110Analyst ForecastSCLXScilex3.4335 of 5 stars$0.56-0.8%$11.33+1,923.8%-48.7%$107.40M$46.74M0.0080Gap UpINMBINmune Bio2.136 of 5 stars$4.84+6.1%$20.00+313.2%-39.1%$107.30M$160,000.00-2.0910VXRTVaxart2.1538 of 5 stars$0.60-1.1%$3.00+399.2%-22.1%$106.64M$7.38M-1.48109Analyst RevisionNews CoveragePositive NewsDERMJourney Medical3.2288 of 5 stars$5.11-2.3%$9.38+83.5%N/A$105.93M$79.18M-5.5690Analyst RevisionNews Coverage Related Companies and Tools Related Companies Liminal BioSciences Competitors Enlivex Therapeutics Competitors Celyad Oncology Competitors Sigilon Therapeutics Competitors Alto Neuroscience Competitors Rani Therapeutics Competitors Scilex Competitors INmune Bio Competitors Vaxart Competitors Journey Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCWB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HCW Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HCW Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCWB Stock Alerts